phenyl-2-aminoethylselenide has been researched along with Cognitive Dysfunction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhowail, AH; Arnold, RD; Bhattacharya, D; Bhattacharya, S; Bloemer, J; Buabeid, MA; Dhanasekaran, M; Eggert, M; Escobar, M; Piazza, G; Pinky, PD; Reed, MN; Smith, B; Suppiramaniam, V; Woodie, L | 1 |
1 other study(ies) available for phenyl-2-aminoethylselenide and Cognitive Dysfunction
| Article | Year |
|---|---|
Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatment.
Topics: Animals; Cognition; Cognitive Dysfunction; Doxorubicin; Hippocampus; Long-Term Potentiation; Male; Mice; Proto-Oncogene Proteins c-akt | 2023 |